Drug Information

Drug General Information
Drug ID
D0L0SD
Former ID
DNC013583
Drug Name
N,N'-(1',3'-propylene)-bis-(-)-nor-MEP
Drug Type
Small molecular drug
Indication Discovery agent Investigative [529368]
Formula
C31H46N2O2
Canonical SMILES
CCC1(CCCCN(C1)CCCN2CCCCC(C2)(CC)C3=CC(=CC=C3)O)C4=CC(=C<br />C=C4)O
InChI
1S/C31H46N2O2/c1-3-30(26-12-9-14-28(34)22-26)16-5-7-18-32(24-30)20-11-21-33-19-8-6-17-31(4-2,25-33)27-13-10-15-29(35)23-27/h9-10,12-15,22-23,34-35H,3-8,11,16-21,24-25H2,1-2H3/t30-,31-/m1/s1
InChIKey
SKYWWOFBHWQWFU-FIRIVFDPSA-N
PubChem Compound ID
24827411
Target and Pathway
Target(s) Cholinesterase Target Info Inhibitor [529368]
PANTHER Pathway Muscarinic acetylcholine receptor 1 and 3 signaling pathway
Muscarinic acetylcholine receptor 2 and 4 signaling pathway
Nicotinic acetylcholine receptor signaling pathway
WikiPathways Irinotecan Pathway
References
Ref 529368J Med Chem. 2008 Apr 10;51(7):2027-36. Epub 2008 Mar 12.Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.
Ref 529368J Med Chem. 2008 Apr 10;51(7):2027-36. Epub 2008 Mar 12.Bis-(-)-nor-meptazinols as novel nanomolar cholinesterase inhibitors with high inhibitory potency on amyloid-beta aggregation.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.